Matches in Wikidata for { <http://www.wikidata.org/entity/Q61909659> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q61909659 description "assaig clínic" @default.
- Q61909659 description "clinical trial" @default.
- Q61909659 description "clinical trial" @default.
- Q61909659 description "clinical trial" @default.
- Q61909659 description "clinical trial" @default.
- Q61909659 description "ensaio clínico" @default.
- Q61909659 description "ensayo clínico" @default.
- Q61909659 description "ensayu clínicu" @default.
- Q61909659 description "essai clinique" @default.
- Q61909659 description "klinisch onderzoek" @default.
- Q61909659 description "клінічне випробування" @default.
- Q61909659 description "կլինիկական փորձարկում" @default.
- Q61909659 description "临床试验" @default.
- Q61909659 name "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects" @default.
- Q61909659 type Item @default.
- Q61909659 label "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects" @default.
- Q61909659 prefLabel "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects" @default.
- Q61909659 P1132 Q61909659-53F451A8-BD05-489D-92F1-FEC32D9F6AAB @default.
- Q61909659 P1476 Q61909659-26FB5B74-1FA6-417C-97BE-9236E95996C4 @default.
- Q61909659 P17 Q61909659-0EC8182E-64A8-46BB-993A-5D4852842B3F @default.
- Q61909659 P1813 Q61909659-11B0F7A2-4D77-4F49-831A-FCBB73804ED3 @default.
- Q61909659 P2899 Q61909659-FAA79E22-3BC3-4BF0-A693-528F7932A8F2 @default.
- Q61909659 P3098 Q61909659-499D6EE7-0424-45A8-804E-BE0B45D9AFE0 @default.
- Q61909659 P31 Q61909659-699FAFCD-8581-4731-AC3C-8C02CC3C8B25 @default.
- Q61909659 P4135 Q61909659-74B3834A-34DC-48E3-BF40-57130BB50AE3 @default.
- Q61909659 P580 Q61909659-1BC69DC9-45D2-4742-896A-067A6432F091 @default.
- Q61909659 P582 Q61909659-465F87D1-436F-46FA-AD14-821D6B1B3DE8 @default.
- Q61909659 P6099 Q61909659-1BF55183-A7F8-4FDE-92D9-F3D28603F5AC @default.
- Q61909659 P8005 Q61909659-D26AD885-2092-473F-A3A6-0B89FCCE76DD @default.
- Q61909659 P8363 Q61909659-72F1B634-62A7-473D-A0D7-8CA5A04D30AC @default.
- Q61909659 P921 Q61909659-9C3B1ACB-2DA2-46F9-8F3A-9D06B8C34998 @default.
- Q61909659 P921 Q61909659-AD0B8227-1918-4CE2-A852-FE4902BD8DAB @default.
- Q61909659 P921 Q61909659-CA103AEE-2EFD-4877-8A25-42649EF9638B @default.
- Q61909659 P921 Q61909659-F8B42E0F-BBB2-4983-B83F-D4EB5E8A4507 @default.
- Q61909659 P1132 "+64" @default.
- Q61909659 P1476 "A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-911 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects" @default.
- Q61909659 P17 Q30 @default.
- Q61909659 P1813 "SUVN-911" @default.
- Q61909659 P2899 "+18" @default.
- Q61909659 P3098 "NCT03155503" @default.
- Q61909659 P31 Q30612 @default.
- Q61909659 P4135 "+45" @default.
- Q61909659 P580 "2017-05-22T00:00:00Z" @default.
- Q61909659 P582 "2018-03-07T00:00:00Z" @default.
- Q61909659 P6099 Q5452194 @default.
- Q61909659 P8005 Q76651189 @default.
- Q61909659 P8363 Q78089383 @default.
- Q61909659 P921 Q10566551 @default.
- Q61909659 P921 Q323936 @default.
- Q61909659 P921 Q42844 @default.
- Q61909659 P921 Q7814214 @default.